Mucosal immunology Virology

The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018.

 

Immunotherapy can be defined as the Treatment to stimulate or restore the ability of the immune (defence) system to fight infection and disease. Biological therapy is thus any form of treatment that uses the body's natural abilities that constitute the immune system to fight infection and disease or to protect the body from some of the side effects of treatment. Chemotherapy and radiation therapy are two of the most effective treatment approaches for cancer

  • Chemotherapy
  • Radiotherapy
  • Cellular immunotherapy
  • Cancer immunotherapy
  • Antibody therapy
  • Cytokine therapy
  • Immune system stimulation
  • Acquired resistance

Related Conference of Mucosal immunology Virology

March 18-19, 2024

53rd World Congress on Microbiology

Zurich, Switzerland
May 09-10, 2024

16th International Virology Summit

Barcelona, Spain
June 10-11, 2024

5th International Conference on Molecular Microbiology

Barcelona, Spain

Mucosal immunology Virology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in